Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DRTS NASDAQ:IRTC NASDAQ:TMDX NYSE:WRBY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDRTSAlpha Tau Medical$9.80-2.3%$9.22$2.87▼$11.62$905.97M1.19934,464 shs604,634 shsIRTCiRhythm Technologies$110.12+5.2%$115.58$100.85▼$212.00$3.44B1.27524,830 shs837,803 shsTMDXTransMedics Group$73.83-2.2%$81.91$60.10▼$156.00$2.61B1.911.09 million shs822,647 shsWRBYWarby Parker$25.71-4.7%$25.00$14.96▼$31.00$2.89B1.963.45 million shs3.14 million shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDRTSAlpha Tau Medical-2.29%+4.81%-2.39%+38.81%+228.86%IRTCiRhythm Technologies+5.19%+1.18%-5.53%-9.58%-27.05%TMDXTransMedics Group-2.22%-2.62%+7.11%-29.77%-42.11%WRBYWarby Parker-4.61%+2.17%+2.43%+9.96%+16.76%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDRTSAlpha Tau Medical$9.80-2.3%$9.22$2.87▼$11.62$905.97M1.19934,464 shs604,634 shsIRTCiRhythm Technologies$110.12+5.2%$115.58$100.85▼$212.00$3.44B1.27524,830 shs837,803 shsTMDXTransMedics Group$73.83-2.2%$81.91$60.10▼$156.00$2.61B1.911.09 million shs822,647 shsWRBYWarby Parker$25.71-4.7%$25.00$14.96▼$31.00$2.89B1.963.45 million shs3.14 million shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDRTSAlpha Tau Medical-2.29%+4.81%-2.39%+38.81%+228.86%IRTCiRhythm Technologies+5.19%+1.18%-5.53%-9.58%-27.05%TMDXTransMedics Group-2.22%-2.62%+7.11%-29.77%-42.11%WRBYWarby Parker-4.61%+2.17%+2.43%+9.96%+16.76%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDRTSAlpha Tau Medical 2.43Hold$12.6028.57% UpsideIRTCiRhythm Technologies 2.94Moderate Buy$187.3870.16% UpsideTMDXTransMedics Group 2.46Hold$134.5082.18% UpsideWRBYWarby Parker 2.64Moderate Buy$29.5014.74% UpsideCurrent Analyst Ratings BreakdownLatest DRTS, IRTC, WRBY, and TMDX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/22/2026IRTCiRhythm Technologies BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$185.006/18/2026IRTCiRhythm Technologies Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)6/18/2026TMDXTransMedics Group Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$75.00 ➝ $80.006/10/2026IRTCiRhythm Technologies BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$185.006/9/2026TMDXTransMedics Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)6/4/2026DRTSAlpha Tau Medical BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$15.00 ➝ $17.006/2/2026IRTCiRhythm Technologies Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)6/2/2026DRTSAlpha Tau Medical HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$15.006/1/2026IRTCiRhythm Technologies Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$180.00 ➝ $152.006/1/2026IRTCiRhythm Technologies HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/28/2026DRTSAlpha Tau Medical BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$15.00(Data available from 6/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDRTSAlpha Tau MedicalN/AN/AN/AN/A$0.88 per shareN/AIRTCiRhythm Technologies$747.14M4.84N/AN/A$4.74 per share23.23TMDXTransMedics Group$605.49M4.21$3.84 per share19.23$13.79 per share5.35WRBYWarby Parker$890.57M3.09$0.60 per share42.90$3.48 per share7.39Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDRTSAlpha Tau Medical-$42.63M-$0.67N/AN/AN/AN/A-73.23%-52.90%8/10/2026 (Estimated)IRTCiRhythm Technologies-$44.55M-$0.86N/A84.06N/A-3.53%-10.26%-1.39%7/30/2026 (Estimated)TMDXTransMedics Group$190.29M$4.4016.7820.45N/A27.04%22.38%8.46%7/30/2026 (Estimated)WRBYWarby Parker$1.64M$0.021,286.1464.28N/A0.15%2.30%1.18%8/6/2026 (Estimated)Latest DRTS, IRTC, WRBY, and TMDX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/18/2026Q1 2026DRTSAlpha Tau Medical-$0.13-$0.26-$0.13-$0.26$0.05 millionN/A5/7/2026Q1 2026WRBYWarby Parker$0.11$0.03-$0.08$0.03$239.44 million$242.45 million5/5/2026Q1 2026TMDXTransMedics Group$0.62$0.30-$0.32$0.20$174.44 million$173.93 million4/30/2026Q1 2026IRTCiRhythm Technologies-$0.56-$0.35+$0.21-$0.43$194.11 million$199.39 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthDRTSAlpha Tau MedicalN/AN/AN/AN/AN/AIRTCiRhythm TechnologiesN/AN/AN/AN/AN/ATMDXTransMedics GroupN/AN/AN/AN/AN/AWRBYWarby ParkerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDRTSAlpha Tau Medical0.097.797.79IRTCiRhythm Technologies4.035.174.98TMDXTransMedics Group1.706.746.19WRBYWarby ParkerN/A2.332.03Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDRTSAlpha Tau Medical2.65%IRTCiRhythm TechnologiesN/ATMDXTransMedics Group99.67%WRBYWarby Parker93.24%Insider OwnershipCompanyInsider OwnershipDRTSAlpha Tau Medical39.50%IRTCiRhythm Technologies0.98%TMDXTransMedics Group6.90%WRBYWarby Parker16.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDRTSAlpha Tau Medical8090.33 million54.65 millionNo DataIRTCiRhythm Technologies2,40032.86 million32.54 millionOptionableTMDXTransMedics Group21034.56 million32.18 millionOptionableWRBYWarby Parker4,036107.09 million89.10 millionOptionableDRTS, IRTC, WRBY, and TMDX HeadlinesRecent News About These CompaniesVaughan Nelson Investment Management L.P. Purchases 722,627 Shares of Warby Parker Inc. $WRBYJune 22 at 7:11 AM | marketbeat.comWarby Parker (NYSE:WRBY) Director Sells $129,700.00 in StockJune 21 at 4:39 AM | americanbankingnews.comWarby Parker Inc. (NYSE:WRBY) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesJune 21 at 2:31 AM | americanbankingnews.comWarby Parker Inc. (NYSE:WRBY) Given Average Rating of "Moderate Buy" by AnalystsJune 21 at 2:29 AM | marketbeat.comWarby Parker (NYSE:WRBY) Director Sells 5,000 SharesJune 19, 2026 | insidertrades.comWarby Parker (WRBY) Unveils First Line of Intelligent Eyewear Powered by Gemini and Android XRJune 19, 2026 | uk.finance.yahoo.comClough Capital Partners L P Makes New $1.57 Million Investment in Warby Parker Inc. $WRBYJune 18, 2026 | marketbeat.com393,085 Shares in Warby Parker Inc. $WRBY Acquired by Atreides Management LPJune 18, 2026 | marketbeat.comIs Warby Parker (WRBY) One of the Best Up and Coming Stocks to Buy for the Next 3 Years?June 17, 2026 | insidermonkey.comSenator Investment Group LP Takes $8.22 Million Position in Warby Parker Inc. $WRBYJune 16, 2026 | marketbeat.com3 reasons to avoid WRBY and 1 stock to buy insteadJune 16, 2026 | msn.comA Warby Parker Director Sold 10,000 Company Shares. Here's a Deeper Look at the Transaction.June 14, 2026 | fool.comNiles Investment Management LLC Purchases Shares of 63,169 Warby Parker Inc. $WRBYJune 14, 2026 | marketbeat.comInsider Selling: Warby Parker (NYSE:WRBY) Director Sells 10,000 Shares of StockJune 13, 2026 | insidertrades.comWarby Parker Stockholders Back Directors and Executive PayJune 12, 2026 | tipranks.comRational Advisors Inc. Purchases New Position in Warby Parker Inc. $WRBYJune 3, 2026 | marketbeat.comWarby Parker Announces Participation in Upcoming 2026 Baird Global Consumer, Technology & Services ConferenceMay 28, 2026 | businesswire.comKing Luther Capital Management Corp Has $9.22 Million Position in Warby Parker Inc. $WRBYMay 28, 2026 | marketbeat.comWarby Parker Inc. (NYSE:WRBY) Receives Average Recommendation of "Moderate Buy" from AnalystsMay 27, 2026 | marketbeat.comFuture of 'A-Eye': Warby Parker co-CEOs on the company's new AI glassesMay 26, 2026 | youtube.comYWellington Shields Capital Management LLC Buys New Shares in Warby Parker Inc. $WRBYMay 26, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDRTS, IRTC, WRBY, and TMDX Company DescriptionsAlpha Tau Medical NASDAQ:DRTS$9.80 -0.23 (-2.29%) Closing price 06/23/2026 04:00 PM EasternExtended Trading$9.93 +0.13 (+1.33%) As of 07:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.iRhythm Technologies NASDAQ:IRTC$110.12 +5.43 (+5.19%) Closing price 06/23/2026 04:00 PM EasternExtended Trading$110.13 +0.01 (+0.01%) As of 07:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.TransMedics Group NASDAQ:TMDX$73.83 -1.68 (-2.22%) Closing price 06/23/2026 04:00 PM EasternExtended Trading$74.65 +0.82 (+1.11%) As of 07:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.Warby Parker NYSE:WRBY$25.71 -1.28 (-4.74%) Closing price 06/23/2026 03:58 PM EasternExtended Trading$25.65 -0.06 (-0.23%) As of 07:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning These AI Stocks Have Insider Selling, But Buyers Still Have a Reason to Stay Apple’s Intel Deal Arrives at the Right Time for Its Stock Micron’s Sudden Plunge May Be an AI Buying Chance Amazon’s Pullback Deepens as a New FTC Risk Hits the Stock The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch. How Does D-Wave's New Simulator Change the Quantum Computing Landscape? How Intel Is Packaging the Future of American Chips Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
